GlassScriptPrepare for your visit
Nitin Sabharwal
Cardiovascular Disease · New Orleans, LA · NPI 1447614680
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,249.21
in general payments reported to CMS, 2019-2025 · $4,630 in 2025
The $4,630 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Who reported paying
General payments only, top 6 by amount.
- Edwards Lifesciences Corporation $3,995.38
- Abbott Laboratories $1,257.82
- Inari Medical, INC. $318.20
- Pfizer INC. $286.13
- Shockwave Medical, INC $249.47
- Abiomed $241.47
Drugs and devices associated with these payments
Evoque Pascal Triclip Flowtriever Catheter, S Ct Thrombectomy System Kit Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter Impella Vyndaqel Optis General - Tachy Lifevest Protekduo
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Nitin Sabharwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/8802899/nitin-sabharwal